AstraZeneca Annual Report and Form 20-F Information 2008

Cautionary Statement

Cautionary statement regarding forward-looking statements

The purpose of this Annual Report and Form 20-F Information is to provide information to the members of the Company. In order, among other things, to utilise the ’safe harbour’ provisions of the US Private Securities Litigation Reform Act 1995 and the UK Companies Act 2006, we are providing the following cautionary statement: This Annual Report and Form 20-F Information contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. Although we believe our expectations are based on reasonable assumptions, any forward-looking statements, by their nature, involve risks and uncertainties and may be influenced by factors that could cause actual outcomes and results to be materially different from those predicted. The forward-looking statements reflect knowledge and information available at the date of the preparation of this Annual Report and Form 20-F Information and the Company undertakes no obligation to update these forward-looking statements. We identify the forward-looking statements by using the words ’anticipates’, ’believes’, ’expects’, ’intends’ and similar expressions in such statements. Important factors that could cause actual results to differ materially from those contained in forwardlooking statements, certain of which are beyond our control, include, among other things, those factors identified in the Principal Risks and Uncertainties section of this document. Nothing in this Annual Report and Form 20-F Information should be construed as a profit forecast.